Sun Pharma Launches Corporate Brand Campaign in India by ananthi | May 6, 2025 | UncategorizedRead More
Sun Pharma and Moebius Medical Announce Dual Publications on MM-II’s Phase 2b Clinical Trial Results and Mechanism of Action in Osteoarthritis and Cartilage by ananthi | May 6, 2025 | UncategorizedRead More
Sun Pharma introduces a novel class of drug, Fexuclue®(Fexuprazan) in India for treatment of Erosive Esophagitis by ananthi | May 6, 2025 | UncategorizedRead More
Recent Comments